ABSTRACT -Objectives: The present study was aimed to ascertain the contributions of mitochondrial respiratory chain (MRC) enzymes to the development of liver failure and to the liver pathophysiology of metabolic liver diseases. Methods: We investigated liver samples obtained from 8 patients with liver failure due to unknown etiology and from 15 patients with metabolic disease: ornithine transcarbamylase -matosis, 2 cases. The estimation of MRC enzymes was carried out by the following independent methods; i) blue native polyacrylamide gel electrophoresis (BN-PAGE) in gel enzyme staining, ii) BN-PAGE western blotting, iii) in vitro MRC enzyme assay. Furthermore, we estimated the quantities of mtDNA and nDNA using qPCR. Result: 4 cases with liver failure showed low activities and protein levels of complex I, III and IV. We also performed qPCR and estimated the ratio mtDNA/nDNA using these samples. They all exhibited extremely low ratio. They were diagnosed as mtDNA depletion syndrome. All cases except MMA cases exhibited mildly or moderately suppressed activities of complex I-IV. However, the respective protein levels remained almost normal. MMA cases exhibited low activities and protein levels of complex I, III and IV. In particular, their low activities and protein levels of complex I were noticeable. They all exhibited normal ratios of mtDNA to nDNA. Conclusion: MRC defect might be an etiology of liver failure in a considerable number of patients in Japan. The present study suggested that considera--iology.
INTRODUCTION
Congenital disorders of the mitochondrial respiratory chain enzymes are the most common group of inborn errors of metabolism, affecting at least 1 in 5,000 individuals (Skladal et al., 2003; Thorburn, 2004; Munnich and Rustin, 2001) . It can affect most organ systems, alone or in combination, so it is not surprising that these disorders could be associated with liver disease presenting as liver failure.
A considerable number of patients with liver failure remain undiagnosed in Japan. They often show liver steatosis, suggesting the presence of mitochondrial damage. On the other hand, mitochondrial damage secondary to metabolic disease, which should modify the liver pathoWe present here mitochondrial respiratory disorder and liver disease, especially mitochondrial DNA depletion syndrome and secondary effect to metabolic liver disease.
MATERIALS AND METHODS

Subject
We investigated the mitochondrial respiratory chain enzymes in liver samples obtained from 8 patients with liver failure due to unknown etiology (Table 1) and from 15 patients with metabolic disease: ornithine transcarbamylase deficiency 6 cases; Wilson disease 3 cases; methylmalonic aciduria (MMA) 3 cases, neonatal hemochromatosis 2 cases (Table 2) . 
BN-PAGE western blotting
Expressions of the mitochondrial respiratory chain complex I, II, III and IV proteins in the liver were examined by western blotting using blue native polyacrylamide gel electrophoresis (BN-PAGE) according to the methods described previously (Dabbeni-Sala et al., 2001 ; Schägger et al mitochondria-enriched fraction was separated by BN-PAGE. Immunostaining was performed using a mono-I, 70 kD subunit of complex II, core 1 subunit of complex III and subunit 1 of complex IV (Molecular Probes, Eugene, OR, USA).
Quantitative PCR
The quantitative estimation of mtDNA was performed -mide adenine dinucleotide dehydrogenase 1 (ND1) in mtDNA genome, as previously described (Pagnamenta et al., 2006; He et al., 2002) . To determine the overall abundance of mtDNA, we compared the real-time ampliregulator (CFTR) gene; chosen on account of the lack of single-nucleotide polymorphisms). For both experiments, DNA from six adult liver samples (from needle biopsies, obtained with informed consent) was used as controls, and results are the means of four independent runs, with samples assayed in triplicate in each run.
RESULTS AND DISCUSSION
8 cases with liver failure showed extremely low activities and protein levels of complex I, III and IV (Figs.  1 and 2) . We also performed qPCR and estimated the ratio mtDNA/nDNA using these samples (Fig. 3) . They all exhibited extremely low ratio (2-7%; normal is 60-150%). Based on these data, they were diagnosed as mtDNA depletion syndrome. Thus, the present study showed that primary mitochondrial hepatopathies were mainly caused by mtDNA depletion. In the metabolic liver diseases, all cases except MMA cases exhibited mildly or moderately suppressed activities of complex I, II and IV (also complex II in some cases). However, the respective protein levels remained almost normal in them (Figs. 4 and 5) .
Unlike other metabolic diseases, MMA cases exhibited low activities and protein levels of complex I, III and IV as did patients with mtDNA depletion syndrome. In particular, their low activity and protein levels of complex I was noticeable. Surprisingly, they all exhibited normal ratios of mtDNA to nDNA (Fig. 6 and Table 4 ). However, the mechanism underlying depleted RC proteins in an absence of depletion of mtDNA remains unclear.
The mitochondrial respiratory chain transfers electrons derived from oxidation of sugars, fats and proteins through a series of four enzyme complexes to generate an electrochemical proton gradient. ATP synthase, or complex V, then utilizes this gradient to derive ATP synthesis. This process of oxidative phosphorylation is responsible for bulk of ATP synthesis in virtually all tissue, so it is not surprising that RC dysfunction can affect any or all organ systems including liver (Thorburn, 2004; Munnich and Rustin, 2001 mitochondrial disease, but Kirby et al. (1999) reported that blood lactic acid level was normal in about 20 perour patient usually showed normal blood lactate level.
Recently, BN-PAGE immunoblotting and enzyme staining have been shown to be a powerful diagnostic tool studying these patients. More investigation is required to acquire a better understanding of liver disease mitochondrial respiratory chain disorders.
The present study strongly suggested that considerable disturbance of mitochondrial respiratory chain occurs the pathophysiology of the liver disease. 
